@prefix ns1: <http://example.org/> .
@prefix ns2: <http://example.org/relation/> .

<http://example.org/doc/samplepdf> a ns1:Document ;
    ns1:contains <http://example.org/entity/1q_genomic_change>,
        <http://example.org/entity/60_month_EFS_500_ml_outcome>,
        <http://example.org/entity/60_month_EFS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_500_ml_outcome>,
        <http://example.org/entity/60_month_OS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_AV_2_500_ml_data_point>,
        <http://example.org/entity/AREN0533_study>,
        <http://example.org/entity/AVD150_Treatment>,
        <http://example.org/entity/AVD250_Treatment>,
        <http://example.org/entity/AVD_treatment>,
        <http://example.org/entity/AV_2_treatment>,
        <http://example.org/entity/Adult_Wilms_tumor_condition>,
        <http://example.org/entity/Anne_M_Smets_author>,
        <http://example.org/entity/Arnauld_C_Verschuur_author>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Beatriz_de_Camargo_author>,
        <http://example.org/entity/Bilateral_Wilms_tumour_condition>,
        <http://example.org/entity/CCSK_Medical_Condition>,
        <http://example.org/entity/CDCV_Treatment>,
        <http://example.org/entity/CMN_Medical_Condition>,
        <http://example.org/entity/COGNWTS_trials_study>,
        <http://example.org/entity/COG_Organization>,
        <http://example.org/entity/COG_protocol_protocol>,
        <http://example.org/entity/CT_at_week_10_Procedure>,
        <http://example.org/entity/CT_only_nodules_medical_condition>,
        <http://example.org/entity/Childrens_Oncology_Group_AREN0321_study>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_organization>,
        <http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_study>,
        <http://example.org/entity/Christian_R%C3%BCbe_author>,
        <http://example.org/entity/Christophe_Bergeron_author>,
        <http://example.org/entity/Consensus_Statement_document>,
        <http://example.org/entity/DAngio_G_J_author>,
        <http://example.org/entity/Daw_N_C_author>,
        <http://example.org/entity/Denys_Drash_syndrome_condition>,
        <http://example.org/entity/EFS_probability_metric>,
        <http://example.org/entity/ESRD_condition>,
        <http://example.org/entity/Europe_Region>,
        <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Organization>,
        <http://example.org/entity/ExPO_r_Net_Project>,
        <http://example.org/entity/Filippo_Spreafico_author>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/Furtwangler_R_author>,
        <http://example.org/entity/GPOH_nephroblastoma_study_group_group>,
        <http://example.org/entity/Geert_O_Janssens_author>,
        <http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Gordan_M_Vujanic_author>,
        <http://example.org/entity/Group_AA_patient_group>,
        <http://example.org/entity/Group_BB_patient_group>,
        <http://example.org/entity/Group_CC_patient_group>,
        <http://example.org/entity/HR_statistic>,
        <http://example.org/entity/Ha_T_C_author>,
        <http://example.org/entity/Harm_van_Tinteren_author>,
        <http://example.org/entity/Heidi_Segers_author>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Infant_Wilms_tumours_condition_subcategory>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_Organization>,
        <http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_organization>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Ivo_Leuschner_author>,
        <http://example.org/entity/Jan_Godzinski_author>,
        <http://example.org/entity/Janna_A_Hol_author>,
        <http://example.org/entity/Jesper_Brok_author>,
        <http://example.org/entity/Kathy_Pritchard_Jones_author>,
        <http://example.org/entity/Kremens_B_author>,
        <http://example.org/entity/LogRank_P_statistic>,
        <http://example.org/entity/Log_rank_P_Statistical_Measure>,
        <http://example.org/entity/MRTK_Medical_Condition>,
        <http://example.org/entity/Manfred_Gessler_author>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author>,
        <http://example.org/entity/NSS_procedure>,
        <http://example.org/entity/NSS_surgical_technique>,
        <http://example.org/entity/NWTS_4_study>,
        <http://example.org/entity/NWTS_5_study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_study>,
        <http://example.org/entity/Netherlands_Country>,
        <http://example.org/entity/Norbert_Graf_author>,
        <http://example.org/entity/OS_probability_metric>,
        <http://example.org/entity/Paola_Collini_author>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Prof_Dr_Ivo_Leuschner_person>,
        <http://example.org/entity/RCC_Medical_Condition>,
        <http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author>,
        <http://example.org/entity/SIOP2001_protocol>,
        <http://example.org/entity/SIOP2001_protocol_protocol>,
        <http://example.org/entity/SIOP2001_randomized_controlled_trial_study>,
        <http://example.org/entity/SIOP2001_randomized_trial_clinical_trial>,
        <http://example.org/entity/SIOP2001_study>,
        <http://example.org/entity/SIOP9301_Clinical_Trial>,
        <http://example.org/entity/SIOPRTSG_Organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_entity>,
        <http://example.org/entity/SIOPRTSG_surgical_panel_entity>,
        <http://example.org/entity/SIOP_2001_Clinical_Trial>,
        <http://example.org/entity/SIOP_9GPOH_trial>,
        <http://example.org/entity/SIOP_Pathology_Panel_panel>,
        <http://example.org/entity/SIOP_Renal_Tumour_Study_Group_SIOP_RTSG_group>,
        <http://example.org/entity/SIOP_WT_2001_protocol>,
        <http://example.org/entity/SIOP_database_database>,
        <http://example.org/entity/SIOP_renal_tumour_protocol_Protocol>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/Terenziani_M_author>,
        <http://example.org/entity/UKW3_trial_clinical_trial>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization>,
        <http://example.org/entity/UK_Country>,
        <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Clinical_Protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_entity>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_protocol>,
        <http://example.org/entity/WAGR_syndrome_condition>,
        <http://example.org/entity/Weirich_A_author>,
        <http://example.org/entity/Wilms_tumour_Disease>,
        <http://example.org/entity/Wilms_tumour_condition>,
        <http://example.org/entity/Wilms_tumour_disease>,
        <http://example.org/entity/Wilms_tumours_condition>,
        <http://example.org/entity/Wilms_tumours_disease>,
        <http://example.org/entity/actinomycin_D_Chemical>,
        <http://example.org/entity/actinomycin_D_drug>,
        <http://example.org/entity/actinomycin_D_medication>,
        <http://example.org/entity/adult_patients_population>,
        <http://example.org/entity/anaplasia_condition_detail>,
        <http://example.org/entity/autologous_stem_cell_rescue_ASCR_Treatment>,
        <http://example.org/entity/autologous_stem_cell_rescue_treatment>,
        <http://example.org/entity/blastemal_type_tumours_Disease_Characteristic>,
        <http://example.org/entity/blastemal_type_tumours_Medical_Condition>,
        <http://example.org/entity/camptothecins_Treatment>,
        <http://example.org/entity/carboplatin_medication>,
        <http://example.org/entity/chemotherapy_resistant_disease_Condition>,
        <http://example.org/entity/chemotherapy_treatment>,
        <http://example.org/entity/chest_CT_Diagnostic_Test>,
        <http://example.org/entity/childhood_renal_tumours_disease>,
        <http://example.org/entity/clinical_guidelines_document>,
        <http://example.org/entity/completely_necrotic_metastasis_Disease_Characteristic>,
        <http://example.org/entity/confirm_metastatic_disease_by_histology_Procedure>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_condition>,
        <http://example.org/entity/cyclophosphamide_medication>,
        <http://example.org/entity/diagnostics_field>,
        <http://example.org/entity/doxorubicin_Chemical>,
        <http://example.org/entity/doxorubicin_drug>,
        <http://example.org/entity/doxorubicin_medication>,
        <http://example.org/entity/epithelial_tumour_types_Medical_Condition>,
        <http://example.org/entity/etoposide_medication>,
        <http://example.org/entity/event_free_survival_EFS_Medical_Metric>,
        <http://example.org/entity/focal_anaplasia_type_tumours_Medical_Condition>,
        <http://example.org/entity/four_drug_regimen_Treatment>,
        <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_treatment>,
        <http://example.org/entity/high_dose_therapy_in_recurrent_Wilms_tumour_treatment>,
        <http://example.org/entity/high_risk_blastemal_type_Wilms_tumour_condition>,
        <http://example.org/entity/high_risk_blastemal_type_Wilms_tumours_disease_subtype>,
        <http://example.org/entity/high_risk_diffuse_anaplasia_condition>,
        <http://example.org/entity/high_risk_disease_Risk_Category>,
        <http://example.org/entity/high_risk_risk_level>,
        <http://example.org/entity/initial_diffuse_anaplasia_Disease_Characteristic>,
        <http://example.org/entity/intermediate_risk_disease_Risk_Category>,
        <http://example.org/entity/intermediate_risk_risk_level>,
        <http://example.org/entity/irinotecan_Treatment>,
        <http://example.org/entity/laparoscopic_surgery_procedure>,
        <http://example.org/entity/large_volume_tumours_Medical_Condition>,
        <http://example.org/entity/locoregional_disease_condition>,
        <http://example.org/entity/low_risk_disease_Risk_Category>,
        <http://example.org/entity/low_risk_risk_level>,
        <http://example.org/entity/lung_nodules_35mm_Disease_Characteristic>,
        <http://example.org/entity/lung_nodules_5mm_Disease_Characteristic>,
        <http://example.org/entity/lung_or_metastasis_radiotherapy_Treatment>,
        <http://example.org/entity/lymph_node_sampling_surgical_procedure>,
        <http://example.org/entity/malignant_rhabdoid_tumours_condition>,
        <http://example.org/entity/metastasis_confirmed_Disease_Characteristic>,
        <http://example.org/entity/metastatic_disease_Medical_Condition>,
        <http://example.org/entity/metastatic_disease_condition>,
        <http://example.org/entity/minimally_invasive_surgery_procedure>,
        <http://example.org/entity/mixed_Medical_Condition>,
        <http://example.org/entity/nephrectomy_surgical_procedure>,
        <http://example.org/entity/nephron_sparing_surgery_NSS_classification_classification_system>,
        <http://example.org/entity/no_evidence_of_metastasis_Disease_Characteristic>,
        <http://example.org/entity/no_evidence_of_viable_or_necrotic_tumour_Disease_Characteristic>,
        <http://example.org/entity/no_evidence_of_viable_tumour_Disease_Characteristic>,
        <http://example.org/entity/no_radiotherapy_to_metastases_Treatment>,
        <http://example.org/entity/no_response_to_salvage_treatment_Condition>,
        <http://example.org/entity/novel_compounds_Treatment>,
        <http://example.org/entity/other_site_Disease_Characteristic>,
        <http://example.org/entity/overall_survival_Medical_Metric>,
        <http://example.org/entity/postoperative_chemotherapy_treatment_phase>,
        <http://example.org/entity/proton_therapy_treatment>,
        <http://example.org/entity/pulmonary_nodules_Medical_Condition>,
        <http://example.org/entity/pulmonary_radiotherapy_Treatment>,
        <http://example.org/entity/pulmonary_radiotherapy_treatment>,
        <http://example.org/entity/radiotherapy_procedure>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/relapsed_group_CC_Patient_Group>,
        <http://example.org/entity/renal_tumour_patients_group>,
        <http://example.org/entity/stage_IIIII_regressive_Medical_Condition>,
        <http://example.org/entity/stage_IV_WT_Disease_Stage>,
        <http://example.org/entity/stage_IV_disease_Medical_Condition>,
        <http://example.org/entity/stromal_tumour_types_Medical_Condition>,
        <http://example.org/entity/surgery_procedure>,
        <http://example.org/entity/surgical_guidelines_document>,
        <http://example.org/entity/topotecan_Treatment>,
        <http://example.org/entity/treatment_field>,
        <http://example.org/entity/viable_metastasis_Disease_Characteristic>,
        <http://example.org/entity/vincristine_Chemical>,
        <http://example.org/entity/vincristine_actinomycin_D_plus_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment_regimen>,
        <http://example.org/entity/vincristine_and_irinotecan_treatment>,
        <http://example.org/entity/vincristine_drug>,
        <http://example.org/entity/vincristine_medication>,
        <http://example.org/entity/wwwsiop_rtsgeu_website> .

<http://example.org/entity/60_month_EFS_AVD_500_ml_entity> ns2:associated_with <http://example.org/entity/AVD_entity> .

<http://example.org/entity/60_month_EFS_AV_2_500_ml_entity> ns2:associated_with <http://example.org/entity/AV_2_entity> .

<http://example.org/entity/60_month_OS_AVD_500_ml_entity> ns2:associated_with <http://example.org/entity/AVD_entity> .

<http://example.org/entity/60_month_OS_AV_2_500_ml_entity> ns2:associated_with <http://example.org/entity/AV_2_entity> .

<http://example.org/entity/AREN0533_entity> ns2:studies <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_entity> .

<http://example.org/entity/AVD150_entity> ns2:is_a_treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/AVD250_entity> ns2:is_a_treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Austria_entity> ns2:location_of <http://example.org/entity/St_Anna_KinderspitalCCRI_Vienna_entity> .

<http://example.org/entity/Bilateral_Wilms_tumour_entity> ns2:can_cause <http://example.org/entity/ESRD_entity> ;
    ns2:has_survival_rate <http://example.org/entity/80_entity> .

<http://example.org/entity/CDCV_entity> ns2:is_a_treatment_for <http://example.org/entity/viable_metastasis_entity> .

<http://example.org/entity/COG_protocol_entity> ns2:includes <http://example.org/entity/CT_only_nodules_entity> .

<http://example.org/entity/Consensus_Statement_entity> ns2:targets <http://example.org/entity/renal_tumour_patients_entity> .

<http://example.org/entity/DAngio_G_J_entity> ns2:contributed_to <http://example.org/entity/National_Wilms_Tumor_Study_entity> .

<http://example.org/entity/Daw_N_C_entity> ns2:participated_in <http://example.org/entity/Childrens_Oncology_Group_AREN0321_entity> ;
    ns2:studied_treatment <http://example.org/entity/vincristine_and_irinotecan_entity> .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> ns2:related_to <http://example.org/entity/ExPO_r_Net_entity> .

<http://example.org/entity/France_entity> ns2:location_of <http://example.org/entity/Armand_Trousseau_Hospital_Paris_entity> .

<http://example.org/entity/Furtwangler_R_entity> ns2:member_of <http://example.org/entity/GPOH_nephroblastoma_study_group_entity> .

<http://example.org/entity/Germany_entity> ns2:location_of <http://example.org/entity/University_Hospital_of_Munich_entity> .

<http://example.org/entity/HR_entity> ns2:associated_with <http://example.org/entity/60_month_EFS_500_ml_entity>,
        <http://example.org/entity/60_month_OS_500_ml_entity> .

<http://example.org/entity/Ha_T_C_entity> ns2:proposed_strategy <http://example.org/entity/high_dose_therapy_in_recurrent_Wilms_tumour_entity> .

<http://example.org/entity/Iceland_entity> ns2:part_of <http://example.org/entity/international_collaboration_entity> .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_entity> ns2:developer <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/Italy_entity> ns2:location_of <http://example.org/entity/Azienda_Ospedaliera_Padova_entity> .

<http://example.org/entity/Janna_A_Hol_entity> ns2:contributor <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/Kremens_B_entity> ns2:researched_treatment <http://example.org/entity/autologous_stem_cell_rescue_entity> .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_entity> ns2:contributor <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/NSS_entity> ns2:acceptable_for_treatment_of <http://example.org/entity/Wilms_tumour_entity> ;
    ns2:subject_to <http://example.org/entity/nephron_sparing_surgery_NSS_classification_entity> .

<http://example.org/entity/NWTS_4_entity> ns2:tested <http://example.org/entity/vincristine_actinomycin_D_plus_doxorubicin_entity> .

<http://example.org/entity/NWTS_5_entity> ns2:tested <http://example.org/entity/vincristine_actinomycin_D_plus_doxorubicin_entity> .

<http://example.org/entity/Netherlands_entity> ns2:location_of <http://example.org/entity/Prinses_Maxima_Centrum_Utrecht_entity> .

<http://example.org/entity/Poland_entity> ns2:location_of <http://example.org/entity/Marciniak_Hospital_Wroclaw_entity> .

<http://example.org/entity/Prof_Dr_Ivo_Leuschner_entity> ns2:cochair_and_member_of <http://example.org/entity/SIOP_Pathology_Panel_entity> .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_entity> ns2:evaluates <http://example.org/entity/EFS_probability_entity>,
        <http://example.org/entity/OS_probability_entity> .

<http://example.org/entity/SIOP2001_randomized_trial_entity> ns2:investigates_drug <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/SIOP_Renal_Tumour_Study_Group_SIOP_RTSG_entity> ns2:developed <http://example.org/entity/SIOP_WT_2001_entity> .

<http://example.org/entity/SIOP_database_entity> ns2:captures_outcome_of <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_entity> .

<http://example.org/entity/Spain_entity> ns2:location_of <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Seville_entity> .

<http://example.org/entity/Terenziani_M_entity> ns2:researched <http://example.org/entity/Adult_Wilms_tumor_entity> .

<http://example.org/entity/UKW3_trial_entity> ns2:supports_use_of <http://example.org/entity/actinomycin_D_entity>,
        <http://example.org/entity/vincristine_entity> .

<http://example.org/entity/UK_entity> ns2:location_of <http://example.org/entity/Great_Ormond_Street_Hospital_London_entity> .

<http://example.org/entity/Weirich_A_entity> ns2:participated_in <http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_entity>,
        <http://example.org/entity/SIOP_9GPOH_entity> .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_entity> ns2:is_a_treatment_for <http://example.org/entity/relapsed_group_CC_entity> .

<http://example.org/entity/blastemal_type_tumours_entity> ns2:compared_in <http://example.org/entity/SIOP_2001_and_SIOP9301_entity> .

<http://example.org/entity/camptothecins_entity> ns2:is_a_treatment_for <http://example.org/entity/relapsed_group_CC_entity> .

<http://example.org/entity/carboplatin_entity> ns2:used_in <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/chest_CT_entity> ns2:detects <http://example.org/entity/pulmonary_nodules_entity> .

<http://example.org/entity/childhood_renal_tumours_entity> ns2:subject_of <http://example.org/entity/SIOP2001_protocol_entity> .

<http://example.org/entity/confirm_metastatic_disease_by_histology_entity> ns2:is_a_procedure_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/cyclophosphamide_entity> ns2:used_in <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/etoposide_entity> ns2:used_in <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/event_free_survival_EFS_entity> ns2:associated_with <http://example.org/entity/large_volume_tumours_entity> .

<http://example.org/entity/four_drug_regimen_entity> ns2:is_a_treatment_for <http://example.org/entity/high_risk_disease_entity> .

<http://example.org/entity/intermediate_risk_disease_entity> ns2:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/liver_or_metastasis_radiotherapy_entity> ns2:is_a_treatment_for <http://example.org/entity/high_risk_disease_entity> .

<http://example.org/entity/low_risk_disease_entity> ns2:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/minimally_invasive_surgery_entity> ns2:is_equivalent_to <http://example.org/entity/laparoscopic_surgery_entity> .

<http://example.org/entity/novel_compounds_entity> ns2:is_a_treatment_for <http://example.org/entity/chemotherapy_resistant_disease_entity> .

<http://example.org/entity/proton_therapy_entity> ns2:needs_investigation_before_implementation_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/pulmonary_radiotherapy_entity> ns2:is_a_treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/stage_IV_WT_entity> ns2:is_a_stage_of <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/stromal_tumour_types_and_epithelial_tumour_types_entity> ns2:have <http://example.org/entity/excellent_prognosis_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_entity> ns2:is_a_type_of <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_without_doxorubicin_entity> ns2:used_in <http://example.org/entity/SIOP_2001_entity> .

<http://example.org/entity/1q_genomic_change> a ns1:genomic_change ;
    ns1:name "1q" .

<http://example.org/entity/60_month_EFS_500_ml_entity> ns2:contributes_to <http://example.org/entity/EFS_probability_entity> .

<http://example.org/entity/60_month_EFS_500_ml_outcome> a ns1:outcome ;
    ns1:name "60-month EFS – 500+ ml",
        "60-month EFS – <500 ml" .

<http://example.org/entity/60_month_EFS_AVD_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS - AVD. 500+ ml",
        "60-month EFS - AVD. <500 ml" .

<http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS - AV-2. 500+ ml",
        "60-month EFS - AV-2. <500 ml" .

<http://example.org/entity/60_month_OS_500_ml_entity> ns2:contributes_to <http://example.org/entity/OS_probability_entity> .

<http://example.org/entity/60_month_OS_500_ml_outcome> a ns1:outcome ;
    ns1:name "60-month OS – 500+ ml",
        "60-month OS – <500 ml" .

<http://example.org/entity/60_month_OS_AVD_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS - AVD. 500+ ml",
        "60-month OS - AVD. <500 ml" .

<http://example.org/entity/60_month_OS_AV_2_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS - AV-2. 500+ ml",
        "60-month OS - AV-2. <500 ml" .

<http://example.org/entity/AREN0533_study> a ns1:study ;
    ns1:name "AREN0533" .

<http://example.org/entity/AVD150_Treatment> a ns1:Treatment ;
    ns1:name "AVD150" .

<http://example.org/entity/AVD250_Treatment> a ns1:Treatment ;
    ns1:name "AVD250" .

<http://example.org/entity/AVD_treatment> a ns1:treatment ;
    ns1:name "AVD" .

<http://example.org/entity/AV_2_treatment> a ns1:treatment ;
    ns1:name "AV-2" .

<http://example.org/entity/Adult_Wilms_tumor_condition> a ns1:condition ;
    ns1:name "Adult Wilms’ tumor" .

<http://example.org/entity/Anne_M_Smets_author> a ns1:author ;
    ns1:name "Anne M. Smets" .

<http://example.org/entity/Arnauld_C_Verschuur_author> a ns1:author ;
    ns1:name "Arnauld C. Verschuur" .

<http://example.org/entity/Austria_Country> a ns1:Country ;
    ns1:name "Austria" .

<http://example.org/entity/Beatriz_de_Camargo_author> a ns1:author ;
    ns1:name "Beatriz de Camargo" .

<http://example.org/entity/Bilateral_Wilms_tumour_condition> a ns1:condition ;
    ns1:name "Bilateral Wilms tumour" .

<http://example.org/entity/CCSK_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "CCSK" .

<http://example.org/entity/CDCV_Treatment> a ns1:Treatment ;
    ns1:name "CDCV" .

<http://example.org/entity/CMN_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "CMN" .

<http://example.org/entity/COGNWTS_trials_study> a ns1:study ;
    ns1:name "COG–NWTS trials" .

<http://example.org/entity/COG_Organization> a ns1:Organization ;
    ns1:name "COG" .

<http://example.org/entity/COG_protocol_protocol> a ns1:protocol ;
    ns1:name "COG protocol" .

<http://example.org/entity/CT_at_week_10_Procedure> a ns1:Procedure ;
    ns1:name "CT at week 10" .

<http://example.org/entity/CT_only_nodules_medical_condition> a ns1:medical_condition ;
    ns1:name "CT-only nodules" .

<http://example.org/entity/Childrens_Oncology_Group_AREN0321_study> a ns1:study ;
    ns1:name "Children’s Oncology Group AREN0321" .

<http://example.org/entity/Childrens_Oncology_Group_COG_organization> a ns1:organization ;
    ns1:name "Children’s Oncology Group (COG)" .

<http://example.org/entity/Childrens_Oncology_Group_study_AREN0533_study> a ns1:study ;
    ns1:name "Children’s Oncology Group study AREN0533" .

<http://example.org/entity/Christian_R%C3%BCbe_author> a ns1:author ;
    ns1:name "Christian Rübe" .

<http://example.org/entity/Christophe_Bergeron_author> a ns1:author ;
    ns1:name "Christophe Bergeron" .

<http://example.org/entity/Consensus_Statement_document> a ns1:document ;
    ns1:name "Consensus Statement" .

<http://example.org/entity/DAngio_G_J_author> a ns1:author ;
    ns1:name "D’Angio, G. J." .

<http://example.org/entity/Daw_N_C_author> a ns1:author ;
    ns1:name "Daw, N. C." .

<http://example.org/entity/Denys_Drash_syndrome_condition> a ns1:condition ;
    ns1:name "Denys-Drash syndrome" .

<http://example.org/entity/EFS_probability_metric> a ns1:metric ;
    ns1:name "EFS probability" .

<http://example.org/entity/ESRD_condition> a ns1:condition ;
    ns1:name "ESRD" .

<http://example.org/entity/Europe_Region> a ns1:Region ;
    ns1:name "Europe" .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Organization> a ns1:Organization ;
    ns1:name "European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment" .

<http://example.org/entity/ExPO_r_Net_Project> a ns1:Project ;
    ns1:name "ExPO-r-Net" .

<http://example.org/entity/Filippo_Spreafico_author> a ns1:author ;
    ns1:name "Filippo Spreafico" .

<http://example.org/entity/France_Country> a ns1:Country ;
    ns1:name "France" .

<http://example.org/entity/Furtwangler_R_author> a ns1:author ;
    ns1:name "Furtwangler, R." .

<http://example.org/entity/GPOH_nephroblastoma_study_group_group> a ns1:group ;
    ns1:name "GPOH-nephroblastoma study group" .

<http://example.org/entity/Geert_O_Janssens_author> a ns1:author ;
    ns1:name "Geert O. Janssens" .

<http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author> a ns1:author ;
    ns1:name "Gema L. Ramírez-Villar" .

<http://example.org/entity/Germany_Country> a ns1:Country ;
    ns1:name "Germany" .

<http://example.org/entity/Gordan_M_Vujanic_author> a ns1:author ;
    ns1:name "Gordan M. Vujanic" .

<http://example.org/entity/Group_AA_patient_group> a ns1:patient_group ;
    ns1:name "Group AA" .

<http://example.org/entity/Group_BB_patient_group> a ns1:patient_group ;
    ns1:name "Group BB" .

<http://example.org/entity/Group_CC_patient_group> a ns1:patient_group ;
    ns1:name "Group CC" .

<http://example.org/entity/HR_statistic> a ns1:statistic ;
    ns1:name "HR" .

<http://example.org/entity/Ha_T_C_author> a ns1:author ;
    ns1:name "Ha, T. C." .

<http://example.org/entity/Harm_van_Tinteren_author> a ns1:author ;
    ns1:name "Harm van Tinteren" .

<http://example.org/entity/Heidi_Segers_author> a ns1:author ;
    ns1:name "Heidi Segers" .

<http://example.org/entity/Iceland_Country> a ns1:Country ;
    ns1:name "Iceland" .

<http://example.org/entity/Infant_Wilms_tumours_condition_subcategory> a ns1:condition_subcategory ;
    ns1:name "Infant Wilms tumours" .

<http://example.org/entity/Infant_Wilms_tumours_entity> ns2:considered_for_primary_surgery <http://example.org/entity/nephrectomy_entity> .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_Organization> a ns1:Organization ;
    ns1:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/International_Society_of_Paediatric_Oncology_Renal_Tumour_Study_Group_organization> a ns1:organization ;
    ns1:name "International Society of Paediatric Oncology – Renal Tumour Study Group" .

<http://example.org/entity/Italy_Country> a ns1:Country ;
    ns1:name "Italy" .

<http://example.org/entity/Ivo_Leuschner_author> a ns1:author ;
    ns1:name "Ivo Leuschner" .

<http://example.org/entity/Jan_Godzinski_author> a ns1:author ;
    ns1:name "Jan Godzinski" .

<http://example.org/entity/Janna_A_Hol_author> a ns1:author ;
    ns1:name "Janna A. Hol" .

<http://example.org/entity/Jesper_Brok_author> a ns1:author ;
    ns1:name "Jesper Brok" .

<http://example.org/entity/Kathy_Pritchard_Jones_author> a ns1:author ;
    ns1:name "Kathy Pritchard-Jones" .

<http://example.org/entity/Kremens_B_author> a ns1:author ;
    ns1:name "Kremens, B." .

<http://example.org/entity/LogRank_P_statistic> a ns1:statistic ;
    ns1:name "Log–Rank P" .

<http://example.org/entity/Log_rank_P_Statistical_Measure> a ns1:Statistical_Measure ;
    ns1:name "Log rank P" .

<http://example.org/entity/MRTK_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "MRTK" .

<http://example.org/entity/Manfred_Gessler_author> a ns1:author ;
    ns1:name "Manfred Gessler" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author> a ns1:author ;
    ns1:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/NSS_procedure> a ns1:procedure ;
    ns1:name "NSS" .

<http://example.org/entity/NSS_surgical_technique> a ns1:surgical_technique ;
    ns1:name "NSS" .

<http://example.org/entity/NWTS_4_study> a ns1:study ;
    ns1:name "NWTS-4" .

<http://example.org/entity/NWTS_5_study> a ns1:study ;
    ns1:name "NWTS-5" .

<http://example.org/entity/National_Wilms_Tumor_Study_study> a ns1:study ;
    ns1:name "National Wilms’ Tumor Study" .

<http://example.org/entity/Netherlands_Country> a ns1:Country ;
    ns1:name "Netherlands" .

<http://example.org/entity/Norbert_Graf_author> a ns1:author ;
    ns1:name "Norbert Graf" .

<http://example.org/entity/OS_probability_metric> a ns1:metric ;
    ns1:name "OS probability" .

<http://example.org/entity/Paola_Collini_author> a ns1:author ;
    ns1:name "Paola Collini" .

<http://example.org/entity/Poland_Country> a ns1:Country ;
    ns1:name "Poland" .

<http://example.org/entity/Prof_Dr_Ivo_Leuschner_person> a ns1:person ;
    ns1:name "Prof. Dr Ivo Leuschner" .

<http://example.org/entity/RCC_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "RCC" .

<http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author> a ns1:author ;
    ns1:name "Rhoikos Furtwängler" .

<http://example.org/entity/SIOP2001_entity> ns2:considers <http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_entity> .

<http://example.org/entity/SIOP2001_protocol> a ns1:protocol ;
    ns1:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_protocol_protocol> a ns1:protocol ;
    ns1:name "SIOP–2001 protocol" .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_study> a ns1:study ;
    ns1:name "SIOP−2001 randomized controlled trial" .

<http://example.org/entity/SIOP2001_randomized_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP2001_study> a ns1:study ;
    ns1:name "SIOP−2001" .

<http://example.org/entity/SIOP9301_Clinical_Trial> a ns1:Clinical_Trial ;
    ns1:name "SIOP−93–01" .

<http://example.org/entity/SIOPRTSG_Organization> a ns1:Organization ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_entity> ns2:developed <http://example.org/entity/UMBRELLA_protocol_entity> ;
    ns2:publishes <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_entity> .

<http://example.org/entity/SIOPRTSG_organization> a ns1:organization ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOP_2001_Clinical_Trial> a ns1:Clinical_Trial ;
    ns1:name "SIOP-2001" .

<http://example.org/entity/SIOP_9GPOH_trial> a ns1:trial ;
    ns1:name "SIOP-9/GPOH" .

<http://example.org/entity/SIOP_Pathology_Panel_panel> a ns1:panel ;
    ns1:name "SIOP Pathology Panel" .

<http://example.org/entity/SIOP_Renal_Tumour_Study_Group_SIOP_RTSG_group> a ns1:group ;
    ns1:name "SIOP Renal Tumour Study Group (SIOP-RTSG)" .

<http://example.org/entity/SIOP_WT_2001_protocol> a ns1:protocol ;
    ns1:name "SIOP WT 2001" .

<http://example.org/entity/SIOP_database_database> a ns1:database ;
    ns1:name "SIOP database" .

<http://example.org/entity/SIOP_renal_tumour_protocol_Protocol> a ns1:Protocol ;
    ns1:name "SIOP renal tumour protocol" .

<http://example.org/entity/Spain_Country> a ns1:Country ;
    ns1:name "Spain" .

<http://example.org/entity/Terenziani_M_author> a ns1:author ;
    ns1:name "Terenziani, M." .

<http://example.org/entity/UKW3_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "UKW3 trial" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization> a ns1:organization ;
    ns1:name "UK Children’s Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UK_Country> a ns1:Country ;
    ns1:name "UK" .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA SIOP–RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Clinical_Protocol> a ns1:Clinical_Protocol ;
    ns1:name "UMBRELLA SIOP-RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_Protocol> a ns1:Protocol ;
    ns1:name "UMBRELLA-SIOP-RTSG-2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_entity> ns2:includes_treatment_for <http://example.org/entity/CCSK_MRTK_CMN_RCC_entity> .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns1:Protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_protocol> a ns1:treatment_protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/WAGR_syndrome_condition> a ns1:condition ;
    ns1:name "WAGR syndrome" .

<http://example.org/entity/Weirich_A_author> a ns1:author ;
    ns1:name "Weirich, A." .

<http://example.org/entity/Wilms_tumour_Disease> a ns1:Disease ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_condition> a ns1:condition ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_disease> a ns1:disease ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumours_condition> a ns1:condition ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_disease> a ns1:disease ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_Chemical> a ns1:Chemical ;
    ns1:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_drug> a ns1:drug ;
    ns1:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_entity> ns2:included_in <http://example.org/entity/postoperative_chemotherapy_entity> .

<http://example.org/entity/actinomycin_D_medication> a ns1:medication ;
    ns1:name "actinomycin D" .

<http://example.org/entity/adult_patients_population> a ns1:population ;
    ns1:name "adult patients" .

<http://example.org/entity/anaplasia_condition_detail> a ns1:condition_detail ;
    ns1:name "anaplasia" .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_Treatment> a ns1:Treatment ;
    ns1:name "autologous stem cell rescue (ASCR)" .

<http://example.org/entity/autologous_stem_cell_rescue_treatment> a ns1:treatment ;
    ns1:name "autologous stem cell rescue" .

<http://example.org/entity/blastemal_type_tumours_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "blastemal-type tumours" .

<http://example.org/entity/blastemal_type_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "blastemal-type tumours" .

<http://example.org/entity/camptothecins_Treatment> a ns1:Treatment ;
    ns1:name "camptothecins" .

<http://example.org/entity/carboplatin_medication> a ns1:medication ;
    ns1:name "carboplatin" .

<http://example.org/entity/chemotherapy_resistant_disease_Condition> a ns1:Condition ;
    ns1:name "chemotherapy-resistant disease" .

<http://example.org/entity/chemotherapy_treatment> a ns1:treatment ;
    ns1:name "chemotherapy" .

<http://example.org/entity/chest_CT_Diagnostic_Test> a ns1:Diagnostic_Test ;
    ns1:name "chest CT" .

<http://example.org/entity/childhood_renal_tumours_disease> a ns1:disease ;
    ns1:name "childhood renal tumours" .

<http://example.org/entity/clinical_guidelines_document> a ns1:document ;
    ns1:name "clinical guidelines" .

<http://example.org/entity/completely_necrotic_metastasis_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "completely necrotic metastasis" .

<http://example.org/entity/confirm_metastatic_disease_by_histology_Procedure> a ns1:Procedure ;
    ns1:name "confirm metastatic disease by histology" .

<http://example.org/entity/congenital_mesoblastic_nephroma_condition> a ns1:condition ;
    ns1:name "congenital mesoblastic nephroma" .

<http://example.org/entity/cyclophosphamide_medication> a ns1:medication ;
    ns1:name "cyclophosphamide" .

<http://example.org/entity/diagnostics_field> a ns1:field ;
    ns1:name "diagnostics" .

<http://example.org/entity/doxorubicin_Chemical> a ns1:Chemical ;
    ns1:name "doxorubicin" .

<http://example.org/entity/doxorubicin_drug> a ns1:drug ;
    ns1:name "doxorubicin" .

<http://example.org/entity/doxorubicin_entity> ns2:included_in <http://example.org/entity/UMBRELLA_protocol_entity> ;
    ns2:recommended_for <http://example.org/entity/large_volume_tumours_entity> ;
    ns2:used_in <http://example.org/entity/chemotherapy_entity> .

<http://example.org/entity/doxorubicin_medication> a ns1:medication ;
    ns1:name "doxorubicin" .

<http://example.org/entity/epithelial_tumour_types_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "epithelial tumour types" .

<http://example.org/entity/etoposide_medication> a ns1:medication ;
    ns1:name "etoposide" .

<http://example.org/entity/event_free_survival_EFS_Medical_Metric> a ns1:Medical_Metric ;
    ns1:name "event-free survival (EFS)" .

<http://example.org/entity/focal_anaplasia_type_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "focal anaplasia-type tumours" .

<http://example.org/entity/four_drug_regimen_Treatment> a ns1:Treatment ;
    ns1:name "four-drug regimen" .

<http://example.org/entity/high_dose_chemotherapy_and_autologous_stem_cell_transplantation_treatment> a ns1:treatment ;
    ns1:name "high-dose chemotherapy and autologous stem cell transplantation" .

<http://example.org/entity/high_dose_therapy_in_recurrent_Wilms_tumour_treatment> a ns1:treatment ;
    ns1:name "high dose therapy in recurrent Wilms’ tumour" .

<http://example.org/entity/high_risk_blastemal_type_Wilms_tumour_condition> a ns1:condition ;
    ns1:name "high-risk blastemal-type Wilms tumour" .

<http://example.org/entity/high_risk_blastemal_type_Wilms_tumours_disease_subtype> a ns1:disease_subtype ;
    ns1:name "high-risk, blastemal-type Wilms tumours" .

<http://example.org/entity/high_risk_diffuse_anaplasia_condition> a ns1:condition ;
    ns1:name "high-risk diffuse anaplasia" .

<http://example.org/entity/high_risk_disease_Risk_Category> a ns1:Risk_Category ;
    ns1:name "high-risk disease" .

<http://example.org/entity/high_risk_risk_level> a ns1:risk_level ;
    ns1:name "high-risk" .

<http://example.org/entity/initial_diffuse_anaplasia_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "initial diffuse anaplasia" .

<http://example.org/entity/intermediate_risk_disease_Risk_Category> a ns1:Risk_Category ;
    ns1:name "intermediate-risk disease" .

<http://example.org/entity/intermediate_risk_risk_level> a ns1:risk_level ;
    ns1:name "intermediate-risk" .

<http://example.org/entity/irinotecan_Treatment> a ns1:Treatment ;
    ns1:name "irinotecan" .

<http://example.org/entity/laparoscopic_surgery_procedure> a ns1:procedure ;
    ns1:name "laparoscopic surgery" .

<http://example.org/entity/large_volume_tumours_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "large-volume tumours" .

<http://example.org/entity/locoregional_disease_condition> a ns1:condition ;
    ns1:name "locoregional disease" .

<http://example.org/entity/low_risk_disease_Risk_Category> a ns1:Risk_Category ;
    ns1:name "low-risk disease" .

<http://example.org/entity/low_risk_risk_level> a ns1:risk_level ;
    ns1:name "low-risk" .

<http://example.org/entity/lung_nodules_35mm_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "lung nodules 3–5mm" .

<http://example.org/entity/lung_nodules_5mm_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "lung nodules >5mm" .

<http://example.org/entity/lung_or_metastasis_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "lung or metastasis radiotherapy" .

<http://example.org/entity/lymph_node_sampling_surgical_procedure> a ns1:surgical_procedure ;
    ns1:name "lymph node sampling" .

<http://example.org/entity/malignant_rhabdoid_tumours_condition> a ns1:condition ;
    ns1:name "malignant rhabdoid tumours" .

<http://example.org/entity/metastasis_confirmed_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "metastasis confirmed" .

<http://example.org/entity/metastatic_disease_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "metastatic disease" .

<http://example.org/entity/metastatic_disease_condition> a ns1:condition ;
    ns1:name "metastatic disease" .

<http://example.org/entity/metastatic_disease_entity> ns2:associated_with <http://example.org/entity/stage_IV_disease_entity> .

<http://example.org/entity/minimally_invasive_surgery_procedure> a ns1:procedure ;
    ns1:name "minimally invasive surgery" .

<http://example.org/entity/mixed_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "mixed" .

<http://example.org/entity/nephrectomy_surgical_procedure> a ns1:surgical_procedure ;
    ns1:name "nephrectomy" .

<http://example.org/entity/nephron_sparing_surgery_NSS_classification_classification_system> a ns1:classification_system ;
    ns1:name "nephron-sparing surgery (NSS) classification" .

<http://example.org/entity/no_evidence_of_metastasis_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "no evidence of metastasis" .

<http://example.org/entity/no_evidence_of_viable_or_necrotic_tumour_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "no evidence of viable or necrotic tumour" .

<http://example.org/entity/no_evidence_of_viable_tumour_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "no evidence of viable tumour" .

<http://example.org/entity/no_radiotherapy_to_metastases_Treatment> a ns1:Treatment ;
    ns1:name "no radiotherapy to metastases" .

<http://example.org/entity/no_response_to_salvage_treatment_Condition> a ns1:Condition ;
    ns1:name "no response to salvage treatment" .

<http://example.org/entity/novel_compounds_Treatment> a ns1:Treatment ;
    ns1:name "novel compounds" .

<http://example.org/entity/other_site_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "other site" .

<http://example.org/entity/overall_survival_Medical_Metric> a ns1:Medical_Metric ;
    ns1:name "overall survival" .

<http://example.org/entity/postoperative_chemotherapy_treatment_phase> a ns1:treatment_phase ;
    ns1:name "postoperative chemotherapy" .

<http://example.org/entity/proton_therapy_treatment> a ns1:treatment ;
    ns1:name "proton therapy" .

<http://example.org/entity/pulmonary_nodules_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "pulmonary nodules" .

<http://example.org/entity/pulmonary_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "pulmonary radiotherapy" .

<http://example.org/entity/pulmonary_radiotherapy_treatment> a ns1:treatment ;
    ns1:name "pulmonary radiotherapy" .

<http://example.org/entity/radiotherapy_entity> ns2:used_for <http://example.org/entity/locoregional_disease_entity>,
        <http://example.org/entity/metastatic_disease_entity> ;
    ns2:was_refined_based_on <http://example.org/entity/COGNWTS_trials_entity>,
        <http://example.org/entity/SIOP2001_entity> .

<http://example.org/entity/radiotherapy_procedure> a ns1:procedure ;
    ns1:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment> a ns1:treatment ;
    ns1:name "radiotherapy" .

<http://example.org/entity/relapsed_group_CC_Patient_Group> a ns1:Patient_Group ;
    ns1:name "relapsed group CC" .

<http://example.org/entity/renal_tumour_patients_group> a ns1:group ;
    ns1:name "renal tumour patients" .

<http://example.org/entity/stage_IIIII_regressive_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "stage II–III regressive" .

<http://example.org/entity/stage_IV_WT_Disease_Stage> a ns1:Disease_Stage ;
    ns1:name "stage IV WT" .

<http://example.org/entity/stage_IV_disease_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "stage IV disease" .

<http://example.org/entity/stromal_tumour_types_Medical_Condition> a ns1:Medical_Condition ;
    ns1:name "stromal tumour types" .

<http://example.org/entity/surgery_entity> ns2:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/surgery_procedure> a ns1:procedure ;
    ns1:name "surgery" .

<http://example.org/entity/surgical_guidelines_document> a ns1:document ;
    ns1:name "surgical guidelines" .

<http://example.org/entity/topotecan_Treatment> a ns1:Treatment ;
    ns1:name "topotecan" .

<http://example.org/entity/treatment_field> a ns1:field ;
    ns1:name "treatment" .

<http://example.org/entity/viable_metastasis_Disease_Characteristic> a ns1:Disease_Characteristic ;
    ns1:name "viable metastasis" .

<http://example.org/entity/vincristine_Chemical> a ns1:Chemical ;
    ns1:name "vincristine" .

<http://example.org/entity/vincristine_actinomycin_D_plus_doxorubicin_treatment> a ns1:treatment ;
    ns1:name "vincristine, actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment_regimen> a ns1:treatment_regimen ;
    ns1:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_irinotecan_treatment> a ns1:treatment ;
    ns1:name "vincristine and irinotecan" .

<http://example.org/entity/vincristine_drug> a ns1:drug ;
    ns1:name "vincristine" .

<http://example.org/entity/vincristine_entity> ns2:included_in <http://example.org/entity/postoperative_chemotherapy_entity> .

<http://example.org/entity/vincristine_medication> a ns1:medication ;
    ns1:name "vincristine" .

<http://example.org/entity/wwwsiop_rtsgeu_website> a ns1:website ;
    ns1:name "www.siop-rtsg.eu" .

<http://example.org/entity/AVD_entity> ns2:consists_of <http://example.org/entity/actinomycin_D_vincristine_and_doxorubicin_entity> .

<http://example.org/entity/AV_2_entity> ns2:consists_of <http://example.org/entity/actinomycin_D_vincristine_27_weeks_entity> .

<http://example.org/entity/SIOPRTSG_panel_entity> a ns1:entity ;
    ns1:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOPRTSG_surgical_panel_entity> a ns1:entity ;
    ns1:name "SIOP−RTSG surgical panel" .

<http://example.org/entity/high_risk_disease_entity> ns2:is_associated_with <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/large_volume_tumours_entity> ns2:subset_of <http://example.org/entity/stage_IIIII_regressive_mixed_and_focal_anaplasia_type_tumours_entity> .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ns2:available_on <http://example.org/entity/wwwsiop_rtsgeu_entity> ;
    ns2:research_focus <http://example.org/entity/1q_entity> ;
    ns2:successor_of <http://example.org/entity/SIOP2001_protocol_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> a ns1:entity ;
    ns1:name "UMBRELLA protocol" ;
    ns2:adopts <http://example.org/entity/nephron_sparing_surgery_NSS_classification_entity> ;
    ns2:applied_in <http://example.org/entity/Europe_entity> ;
    ns2:defines_treatment_for <http://example.org/entity/Group_AA_entity>,
        <http://example.org/entity/Group_BB_entity>,
        <http://example.org/entity/Group_CC_entity> ;
    ns2:emphasizes_importance_of <http://example.org/entity/lymph_node_sampling_entity> ;
    ns2:facilitates <http://example.org/entity/international_collaboration_entity> ;
    ns2:guides_treatment_for <http://example.org/entity/Wilms_tumour_entity> ;
    ns2:includes <http://example.org/entity/CT_only_nodules_entity> ;
    ns2:is_protocol_for <http://example.org/entity/Wilms_tumours_entity> ;
    ns2:provides_guidelines_for <http://example.org/entity/radiotherapy_entity>,
        <http://example.org/entity/surgery_entity> ;
    ns2:recommends_consulting <http://example.org/entity/SIOPRTSG_panel_entity> ;
    ns2:recommends_discussion_for_NSS <http://example.org/entity/SIOPRTSG_surgical_panel_entity> ;
    ns2:specifies <http://example.org/entity/surgical_guidelines_entity> ;
    ns2:standardized_by <http://example.org/entity/SIOPRTSG_entity> .

<http://example.org/entity/Wilms_tumour_entity> ns2:affects <http://example.org/entity/adult_patients_entity> ;
    ns2:includes <http://example.org/entity/Infant_Wilms_tumours_entity> ;
    ns2:subject_of <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

